皮膚代替物市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

世界の皮膚代替物市場は、2024年に3億6,545万米ドルと評価され、2030年には5億8,610万米ドルに達し、CAGR 8.15%で成長する見通しです。

慢性創傷、重度の火傷、外傷性皮膚損傷などの症例が増加しており、高度な創傷ケアソリューションが必要とされているため、市場は急速に拡大しています。これらの製品は、従来の治療ではうまくいかなかった皮膚の再生を促進します。高齢者人口の増加、糖尿病や肥満などの合併症の増加、バイオマテリアルや再生医療における継続的な進歩が市場の勢いを支えています。地域のヘルスケアニーズや臨床需要に沿った戦略をとる企業は、将来の成長機会を獲得する上で競争優位に立つことが期待されます。

市場促進要因

慢性創傷と急性創傷の発生率の増加

主な市場課題

皮膚代替製品の高コストと新興市場における償還制限

主要市場動向

3Dバイオプリンティングと個別化医療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 皮膚代替物市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（生物学的、合成）
  • 用途別（急性創傷、慢性創傷）
  • エンドユーザー別（病院・診療所、外来手術センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の皮膚代替物市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の皮膚代替物市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の皮膚代替物市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の皮膚代替物市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの皮膚代替物市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の皮膚代替物市場：SWOT分析

第14章 競合情勢

• Amarantus BioScience Holdings, Inc
• Organogenesis Inc.
• Smith+Nephew
• Integra LifeSciences Corporation
• BSN Medical GmbH
• Molnlycke Health Care ABss
• Medtronic Plc
• Tissue Regenix Ltd.
• Stratatech Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Skin Substitutes Market, valued at USD 365.45 million in 2024, is poised to reach USD 586.10 million by 2030, growing at a CAGR of 8.15%. The market is experiencing rapid expansion due to rising cases of chronic wounds, severe burns, and traumatic skin injuries that require advanced wound care solutions. These products facilitate skin regeneration where conventional treatments fail. The growing elderly population, increasing comorbidities such as diabetes and obesity, and ongoing advancements in biomaterials and regenerative medicine are sustaining market momentum. Companies that align their strategies with regional healthcare needs and clinical demands are expected to gain a competitive edge in capturing future growth opportunities.

Key Market Drivers

Rising Incidence of Chronic and Acute Wounds

The growth of the Global Skin Substitutes Market is significantly driven by the increasing prevalence of both chronic and acute wounds. This trend presents considerable clinical and economic impacts, establishing skin substitutes as vital tools in advanced wound care. Chronic conditions like diabetic foot ulcers, pressure sores, and venous leg ulcers are on the rise, especially among elderly patients and those with diabetes, obesity, or vascular disorders. It is estimated that 15% to 34% of diabetic individuals may experience diabetic foot ulcers during their lifetime, indicating a substantial need for specialized wound care. These wounds often persist or recur, necessitating long-term treatment where skin substitutes can accelerate healing and reduce complications. With global prevalence rates of chronic wounds ranging from 1.51 to 2.21 per 1,000 people, the demand for advanced skin replacement therapies is consistent, fueling investment and innovation in this segment.

Key Market Challenges

High Cost of Skin Substitute Products and Limited Reimbursement in Emerging Markets

The elevated costs of bioengineered or cellular-based skin substitutes, stemming from complex production processes and regulatory demands, pose a major barrier to widespread adoption. While cost-effectiveness may be justified in developed regions, price sensitivity in emerging markets restricts accessibility. In many low- and middle-income countries, healthcare budgets are limited and insurance coverage is inadequate, hindering the adoption of high-cost therapies. Even in wealthier nations, restricted reimbursement policies-especially for outpatient use-limit market penetration. Consequently, manufacturers must demonstrate strong clinical and economic benefits to secure coverage, which can slow the pace of adoption and market growth, particularly in Asia-Pacific, Latin America, and Eastern Europe.

Key Market Trends

3D Bioprinting and Personalized Medicine

Technological advancements such as 3D bioprinting, stem cell engineering, and genomic profiling are transforming the skin substitute market. 3D bioprinting allows for the creation of patient-specific skin grafts that align with the wound's shape and tissue structure, enhancing integration and recovery. Personalized medicine enables customization of skin substitutes based on a patient's unique biology, improving therapeutic outcomes. Companies adopting AI-driven modeling and innovative biomaterials are setting new standards for product efficacy. This trend is drawing investor interest and academic partnerships, accelerating commercialization and enabling premium product positioning.

Key Market Players

• Amarantus BioScience Holdings, Inc
• Organogenesis Inc.
• Smith+Nephew
• Integra LifeSciences Corporation
• BSN Medical GmbH
• Molnlycke Health Care ABss
• Medtronic Plc
• Tissue Regenix Ltd.
• Stratatech Corporation

Report Scope:

In this report, the Global Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Substitutes Market, By Type:

• Biological
• Synthetic

Skin Substitutes Market, By Application:

• Acute Wounds
• Chronic Wounds

Skin Substitutes Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Skin Substitutes Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Skin Substitutes Market.

Available Customizations:

Global Skin Substitutes market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Skin Substitutes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Biological, Synthetic)
  • 5.2.2. By Application (Acute Wounds, Chronic Wounds)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Skin Substitutes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Skin Substitutes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Skin Substitutes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Skin Substitutes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Skin Substitutes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Skin Substitutes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Skin Substitutes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Skin Substitutes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Skin Substitutes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Skin Substitutes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Skin Substitutes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Skin Substitutes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Skin Substitutes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Skin Substitutes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Skin Substitutes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Skin Substitutes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Skin Substitutes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Skin Substitutes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Skin Substitutes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Skin Substitutes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Skin Substitutes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Skin Substitutes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Skin Substitutes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Skin Substitutes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Skin Substitutes Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Amarantus BioScience Holdings, Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Organogenesis Inc.
• 14.3. Smith+Nephew
• 14.4. Integra LifeSciences Corporation
• 14.5. BSN Medical GmbH
• 14.6. Molnlycke Health Care ABss
• 14.7. Medtronic Plc
• 14.8. Tissue Regenix Ltd.
• 14.9. Stratatech Corporation

15. Strategic Recommendations

16. About Us & Disclaimer